RHON-KLINIKUM AG

RHON-KLINIKUM AG

14.40
EUR
-0.20
(-1.37%)
0.66EPS
20.18P/E
856.81MMarket Cap
Nov 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
21.81
11.54
15.38
17.57
18.09
18.42
19.48
20.32
20.94
21.6
21.87
23.84
25.47
26.15
Basic EPS, GAAP
0.63
9.36
1.19
0.84
0.53
0.73
0.65
0.02
0.42
0.38
0.58
0.65
0.51
0.63
Free Cash Flow per Basic Share
0.33
-0.34
-0.12
-0.07
-0.53
-1.7
-1
0.24
0.29
0.03
0.69
0.85
-0.63
- -
Dividend per Share
0.25
0.26
0.82
0.8
0.35
0.22
0.29
- -
- -
- -
0.15
- -
0.1
- -
Book Value per Share
11.9
16.72
16.25
16.29
16.47
16.96
17.35
17.41
17.9
18.28
18.7
19.36
19.73
19.86
Tangible Book Value per Share
10.72
14.5
13.77
13.71
13.86
14.32
14.69
14.7
15.19
15.6
16.08
16.76
17.21
17.24
Basic Weighted Avg Shares
138
131
72
67
67
67
67
67
67
67
67
67
67
66
Sales/Revenue/Turnover
3,014
1,511
1,108
1,176
1,211
1,233
1,304
1,360
1,402
1,446
1,464
1,596
1,705
1,735
Operating Margin (%)
5.58
-0.5
8.97
8.98
4.12
5.24
4.21
-0.06
2.12
2.51
2.02
2.35
1.7
2.32
Depreciation Expense
121
82
52
60
59
61
68
70
70
70
66
63
65
65
Net Income, GAAP
87
1,226
85
56
35
49
43
1
28
25
39
43
34
42
Effective Tax Rate (%)
23.51
1.65
3.15
3.66
1.02
18.98
18
37.36
- -
19.89
15.84
19.57
19.28
19.73
Profit Margin (%)
2.88
81.15
7.7
4.8
2.9
3.97
3.32
0.11
2.02
1.74
2.64
2.72
2.02
2.43
Working Capital
1,522
581
252
203
182
237
301
293
338
398
454
499
549
562
LT Debt
695
154
14
3
3
104
168
157
156
147
146
115
118
- -
Total Equity
1,667
1,249
1,109
1,113
1,125
1,159
1,186
1,190
1,225
1,251
1,280
1,326
1,352
1,360
Return on Invested Capital (%)
4.63
67.32
6.75
7.86
3.45
4.41
3.49
0.48
- -
2.03
2.36
2.62
2.2
3.02
Return on Capital (%)
4.46
67.45
6.72
7.5
3.05
4.05
3.39
0.37
- -
1.91
2.84
3.04
2.39
3.16
Return on Common Equity (%)
5.37
85.31
7.37
5.18
3.21
4.38
3.77
0.12
2.39
2.08
3.13
3.4
2.63
3.2

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4
- -
- -
LT Borrowings
111
- -
- -
LT Finance Leases
7
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
67
67
Market Capitalization
837
823
857

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
890
915
907
Cash, Cash Equivalents & STI
342
578
557
Accounts Receivable, Net
278
257
264
Inventories
41
43
44
Total Current Liabilities
342
356
345
Payables & Accruals
- -
- -
- -
ST Debt
4
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.01%
2.58%
1.94%
Free Cash Flow
259.34%
376.42%
-173.25%
Net Income, GAAP
174.38%
376.87%
-20.48%
Sales/Revenue/Turnover
4.43%
4.66%
6.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
383
393
396
425
1,596
2025
415
419
429
443
1,705
2026
436
427
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.16
0.14
0.14
0.21
0.65
2025
0.11
0.1
0.15
0.16
0.51
2026
0.19
0.14
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.1
2026
- -
- -
- -
- -
- -

Company Description

CEO
Tobias Kaltenbach
Full Time Employees
19,128
Sector
Health services
Industry
Hospital/Nursing management
Address
Salzburger Leite 1 Bad Neustadt an der Saale BV Germany 97616
IPO Date
Nov 27, 1989
Business
RHÖN-KLINIKUM AG operates as one of Germany's largest healthcare providers, delivering inpatient, semi-inpatient, and outpatient medical services through acute hospitals, medical care centers, and rehabilitation hospitals; its core facilities include the highly specialized RHÖN-KLINIKUM Campus Bad Neustadt with six clinics offering cardiological, surgical, psychiatric, neurological, neurosurgical, orthopedic, addiction treatment, and physical therapy services, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen und Marburg (UKGM), and Zentralklinik Bad Berka, all functioning as maximum- and intermediate-care providers with direct ties to universities and research facilities. The company, founded in 1973 and headquartered in Bad Neustadt an der Saale, Germany, generates all revenue domestically, primarily from Bavaria and Hesse regions, treating over 912,000 patients annually across its sites while emphasizing innovation in digitalization, outpatient care expansion, and intersectoral cooperation. Recent developments include sustained revenue growth to €1.60 billion in 2024 with €45.2 million consolidated profit, ongoing investments under the White Paper Plus agreement with Hesse totaling €850 million by 2032 for modernizing surgery wings, building a new adult psychiatry clinic in Marburg, expanding Giessen's surgical clinic, and acquiring advanced medical equipment, alongside pioneering digital initiatives such as the high-speed telematics infrastructure connector licensed by Gematik in 2024, AI-based "DokPro" emergency assessment at Marburg, and the HOUSE OF BEST CARE concept for enhanced staffing, training, and patient journeys; CEO Prof. Dr. Tobias Kaltenbach departed the Board as planned in 2025, with the company confirming outlook for €1.7 billion revenues and €110-125 million EBITDA in 2025 amid solid Q3 performance showing 7.8% revenue increase to €1.26 billion for the first nine months.